Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
出版年份 2020 全文链接
标题
Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
作者
关键词
-
出版物
Current Atherosclerosis Reports
Volume 22, Issue 8, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-18
DOI
10.1007/s11883-020-00858-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
- (2020) Raul D. Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia
- (2020) et al. JAMA Cardiology
- Case report: The efficiency and safety of lomitapide in a homozygous familial hypercholesterolemic child
- (2019) Ana Paula M. Chacra et al. Journal of Clinical Lipidology
- Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
- (2019) Tawfeg Ben-Omran et al. ADVANCES IN THERAPY
- A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolaemia: the Sino-Roman Study
- (2019) Claudia Stefanutti et al. Journal of Clinical Lipidology
- Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia
- (2019) Genovefa Kolovou et al. European Journal of Preventive Cardiology
- Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia
- (2018) Raul D. Santos ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Autosomal recessive hypercholesterolemia in Spain
- (2018) Rosa María Sánchez-Hernández et al. ATHEROSCLEROSIS
- A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
- (2018) Meral Kayikcioglu et al. ATHEROSCLEROSIS
- Lomitapide in homozygous familial hypercholesterolemia
- (2018) Simona Sperlongano et al. Journal of Cardiovascular Medicine
- Long-term liver safety of lomitapide in patients with homozygous familial hypercholesterolemia: Three-year data from the lomitapide observational worldwide evaluation registry (LOWER)
- (2018) D. Larrey et al. JOURNAL OF HEPATOLOGY
- Autosomal Recessive Hypercholesterolemia
- (2018) Laura D’Erasmo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
- (2018) Dirk J. Blom et al. Orphanet Journal of Rare Diseases
- Clinical, demographic and genetic characteristics of homozygous familial hypercholesterolemia patients worldwide: Interim results from the hofh international clinical collaborators (HICC) registry
- (2018) M. Hartgers et al. ATHEROSCLEROSIS
- Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study
- (2018) Atsushi Nohara et al. Journal of Atherosclerosis and Thrombosis
- Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
- (2017) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs
- (2017) Claudia Stefanutti et al. Journal of Clinical Lipidology
- The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis
- (2017) Robert Leipold et al. European Journal of Preventive Cardiology
- Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
- (2017) Frederick J Raal et al. Lancet Diabetes & Endocrinology
- Limitations of cholesterol lowering with PCSK9 inhibitors
- (2017) Gilbert Thompson Lancet Diabetes & Endocrinology
- Unmet Needs in LDL-C Lowering: When Statins Won’t Do!
- (2016) Stephan Krähenbühl et al. DRUGS
- MTP Gene Variants and Response to Lomitapide in Patients with Homozygous Familial Hypercholesterolemia
- (2016) Genovefa D Kolovou et al. Journal of Atherosclerosis and Thrombosis
- Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis
- (2016) Claudia Stefanutti et al. Journal of Clinical Lipidology
- Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
- (2015) Abdullah Al-Ashwal et al. Current Vascular Pharmacology
- Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia
- (2015) Anna Raper et al. Journal of Clinical Lipidology
- Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide
- (2015) Jeanine Roeters van Lennep et al. Journal of Clinical Lipidology
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: Insights from a patient survey
- (2014) Eric Bruckert et al. ATHEROSCLEROSIS SUPPLEMENTS
- Lomitapide and Mipomersen
- (2014) Daniel J. Rader et al. CIRCULATION
- Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances
- (2014) Claudia Stefanutti et al. Current Atherosclerosis Reports
- Hypobetalipoproteinemia and abetalipoproteinemia
- (2014) Francine K. Welty CURRENT OPINION IN LIPIDOLOGY
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
- (2014) Barbara Sjouke et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- (2012) Frederick J. Raal et al. ATHEROSCLEROSIS
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
- (2011) Frederick J. Raal et al. CIRCULATION
- Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia
- (2011) Claudia Stefanutti et al. CYTOKINE
- Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
- (2010) Gilbert R Thompson et al. CURRENT OPINION IN LIPIDOLOGY
- Efficacy criteria and cholesterol targets for LDL apheresis
- (2009) Gilbert R. Thompson et al. ATHEROSCLEROSIS
- Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levels
- (2009) D. Steinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia
- (2008) Lisa C. Hudgins et al. AMERICAN JOURNAL OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started